HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-6.86%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$166M
AUM Growth
+$166M
(+5.3%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
15.39%
Top 10 Holdings %
Top 10 Hldgs %
40.91%
Holding
125
New
39
Increased
43
Reduced
18
Closed
15
Top Buys
| 1 |
Mastercard
MA
|
$4.04M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$3.45M |
| 3 |
TEGNA Inc
TGNA
|
$3.02M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$2.39M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$2.23M |
Top Sells
| 1 |
PBCT
People's United Financial Inc
PBCT
|
$3.92M |
| 2 |
Fidelity National Information Services
FIS
|
$3.85M |
| 3 |
CERN
Cerner Corp
CERN
|
$3.49M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$979K |
Sector Composition
| 1 | Healthcare | 46.47% |
| 2 | Technology | 22.39% |
| 3 | Financials | 16.85% |
| 4 | Communication Services | 4.29% |
| 5 | Consumer Discretionary | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $745K | 0.45% | 11,096 +1,343 | +14% | +$90.2K |
|
52
Arcutis Biotherapeutics
ARQT
$1.86B
| $734K | 0.44% | +34,462 | New | +$734K |
|
53
Alnylam Pharmaceuticals
ALNY
$58.5B
| $728K | 0.44% | 4,988 -567 | -10% | -$82.8K |
|
54
Sarepta Therapeutics
SRPT
$1.78B
| $718K | 0.43% | 9,581 -1,729 | -15% | -$130K |
|
55
BioMarin Pharmaceuticals
BMRN
$11.2B
| $712K | 0.43% | 8,596 +3,003 | +54% | +$249K |
|
56
Ascendis Pharma
ASND
$11.8B
| $692K | 0.42% | 7,442 -379 | -5% | -$35.2K |
|
57
Xenon Pharmaceuticals
XENE
$2.98B
| $682K | 0.41% | 22,435 -5,557 | -20% | -$169K |
|
58
AnaptysBio
ANAB
$569M
| $672K | 0.41% | 33,103 +19,105 | +136% | +$388K |
|
|
TCDA
59
DELISTED
Tricida, Inc. Common Stock
TCDA
| $664K | 0.4% | 68,548 -38,654 | -36% | -$374K |
|
60
Arvinas
ARVN
$568M
| $660K | 0.4% | +15,686 | New | +$660K |
|
61
Galapagos
GLPG
$2.07B
| $658K | 0.4% | 11,801 -1,408 | -11% | -$78.5K |
|
62
Alphabet (Google) Class C
GOOG
$2.58T
| $647K | 0.39% | +296 | New | +$647K |
|
63
GH Research
GHRS
$837M
| $638K | 0.39% | 63,936 +11,096 | +21% | +$111K |
|
|
MORF
64
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $634K | 0.38% | 29,230 +18,313 | +168% | +$397K |
|
65
Natera
NTRA
$23.1B
| $631K | 0.38% | 17,812 +4,364 | +32% | +$155K |
|
66
Crinetics Pharmaceuticals
CRNX
$2.92B
| $614K | 0.37% | 32,948 -11,278 | -26% | -$210K |
|
|
BPMC
67
DELISTED
Blueprint Medicines
BPMC
| $612K | 0.37% | +12,108 | New | +$612K |
|
68
Vaxcyte
PCVX
$4B
| $609K | 0.37% | +27,965 | New | +$609K |
|
69
Celldex Therapeutics
CLDX
$1.47B
| $604K | 0.36% | 22,412 -3,326 | -13% | -$89.6K |
|
|
HZNP
70
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $592K | 0.36% | 7,419 -837 | -10% | -$66.8K |
|
71
Acadia Pharmaceuticals
ACAD
$4.38B
| $562K | 0.34% | 39,900 +5,784 | +17% | +$81.5K |
|
72
Relmada Therapeutics
RLMD
$37.2M
| $560K | 0.34% | 29,493 +8,112 | +38% | +$154K |
|
|
ISEE
73
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $557K | 0.34% | 57,919 +4,336 | +8% | +$41.7K |
|
74
Amazon
AMZN
$2.44T
| $538K | 0.32% | +5,068 | New | +$538K |
|
75
Viridian Therapeutics
VRDN
$1.5B
| $521K | 0.31% | 45,039 -4,026 | -8% | -$46.6K |
|